This website uses cookies to identify your browser when interacting with the website. By browsing this website, you agree to this website's use of cookies and related privacy policies.

公司理念

禾榮科技

Innovative Treatment Options by AB-BNCT Patients Cured and Maintain Quality of Life

Board of Directors Responsibilities

The board of directors of the Company shall direct company strategies, supervise the management, and be responsible to the Company and shareholders. The various procedures and arrangements of its corporate governance system shall ensure that, in exercising its authority, the board of directors complies with laws, regulations, its Articles of Incorporation, and the resolutions of its shareholders meetings.

Board of Directors
Title Name Election date Principal Academic Qualifications Principal Work Experiences
Chairperson Chin-Yung Shu 2025/01/14 Master's degree in Institute of EO Engineering from National Chiao Tung University
  • Chairperson of Huntertex Corp
  • Chairperson of JadeYale-CY Company Limited
  • Chairperson of Shinyu light Co., Ltd
  • Director of Episil Technologies Inc
  • Director of Giga Solar Materials Corp
  • Director of Hermes-Epitek Corp
Director Archie Hwang 2025/01/14 National Chiao Tung University Department of Electrophysics
  • Chairperson of Hermes-Epitek Corp
Director Sue Lin 2025/01/14 Master's degree in Executive Business Administration from National Chiao Tung
  • Vice Chairperson of Hermes-Epitek Corp
Director Amy Chen 2025/01/14 Master's degree in Accounting from George Washington University
  • The Accounting Research and Development Foundation
  • National Federation Of Certified
  • National Federation Of Certified
Independent director Chyan Yang 2025/01/14
  • Ph.D. in Computer Science & Engineering, University of Washington
  • Master degree in Science in Management Science of National Chiao Tung University
  • Professor, College of Management, National Yang Ming Chiao Tung University.
  • Executive Director of EMBA at National Yang-Ming Chiao Tung University
Independent director Jay Hsieh 2025/01/14
  • Master's degree in Executive Business Administration from National Tsing Hua University
  • Chairperson of Bojal Co., Ltd
  • Chairperson of Izo Health Care Co., Ltd
Independent director Ya-Fang Cheng 2026/05/27
  • Currently enrolled in the Executive Master of Business Administration (EMBA) program at the College of Management, National Taiwan University
  • Master of Laws in Technology Law, School of Law, National Yang Ming Chiao Tung University School of Law
  • Legal Science Division, Department of Law, National Taiwan University
  • Graduate of the 41st batch of trainee judges and prosecutors from the Academy for the Judiciary, Ministry of Justice
  • Passed the 1999 Lawyers Examination of the Republic of China (Taiwan)
  • Completed the introductory accounting credit course, intermediate accounting credit course, auditing credit course, and cost accounting credit course of the Accounting Research and Development Foundation
  • Completed the introductory accounting credit course, intermediate accounting credit course, auditing credit course, and cost accounting credit course of the Accounting Research and Development Foundation
  • Passed the certifications for Labor & Health Insurance and Labor Standards Act Specialist and Labor Laws & Regulations Specialist of the Chinese Human Resource Management Association
  • Passed the certifications for Labor & Health Insurance and Labor Standards Act Specialist and Labor Laws & Regulations Specialist of the Chinese Human Resource Management Association
  • Court-attending Prosecutor for Major Financial Crimes, Taiwan Taipei District Prosecutors Office
  • Prosecutor, Taiwan Keelung District Prosecutors Office
  • Prosecutor, Taiwan Yilan District Prosecutors Office
Diversification policy of the Board of Directors:
  • According to the company's "Corporate Governance Best Practice Principles" Article 20, directors should generally possess the knowledge, skills, and qualities necessary to perform their duties. To achieve the ideal goals of corporate governance, the board of directors as a whole should have the following capabilities:

    • Ability to make operational judgment。 (Business Management)
    • Ability to perform accounting and financial analysis。 (Finance)
    • Ability to conduct management administration (Business Management)
    • Ability to conduct crisis management (Leadership and Decision Making)
    • Knowledge of the industry ( Biotechnology and Medicine Industry)
    • An international market perspective (Marketing Strategy)
    • Ability to lead (Leadership and Decision Making)
    • Ability to make policy decisions (Marketing Strategy)
  • The composition of the board of directors has taken diversity into consideration and formulated an appropriate policy on diversity based on the company’s business operations, operating dynamics, and development needs. According to our company's "Corporate Governance Best Practices," it is advisable that the policy include the following two general standards:

    • Basic requirements and values: Gender, age, nationality, and culture. It is recommended that female directors comprise at least one-third of the board.
    • Professional knowledge and skills: A professional background (e.g., law, accounting, industry, finance, marketing, technology), professional skills, and industry experience.
Diversification and Independence of Board of Directors
  • Currently, our company's Board of Directors consists of seven members with diverse backgrounds, including expertise in various industries and academia. Among the seven directors, three are independent directors. Additionally, three of the board members are women, accounting for one-third of the board seats. The implementation of the board diversity policy is detailed in the table below.

Name/Title Basic Composition Ability and experience Expertise
Gender Nationality Age Also serves as an employee of the Company Length of term of office of independent directors Business management Marketing Strategy Leadership and Decision Making Finance Biotechnology and Medicine Industry

Chin-Yung Shu

Male Taiwan 71-80 - -

Archie Hwang

Male Singapore 71-80 - -

Sue Lin

Female Singapore 71-80 - -

Amy Chen

Female Taiwan 41-50 - -

Chyan Yang

Male Taiwan 71-80 - -

Ya-Fang Cheng

Female Taiwan 41-50 - -

Jay Hsieh

Male Taiwan 51-60 - -
Diversification and Independence of Board of Directors
  • Board of Directors Performance Evaluation

The company has established a board performance evaluation system. In 2024, the board approved the performance evaluation measures for the board of directors, functional committees, and managerial officers, aiming to encourage self-discipline among board members and enhance the effectiveness of board operations. Internal board performance evaluations are conducted annually, while external evaluations are carried out at least once every three years by an independent professional institution or a team of external experts and scholars. The performance evaluation for the current year is conducted at the end of the year, and the results must be completed by the first quarter of the following year.

  • Board of Directors Performance

go top top go top top